Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pirfenidone
Related studies linked through entity extraction aliases.
A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
- Status
- RECRUITING
- Phase
- PHASE1
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
- Status
- RECRUITING
- Phase
- PHASE3
A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
- Status
- RECRUITING
- Phase
- PHASE3
Real-life-persistence to Antifibrotic Treatments
- Status
- COMPLETED
- Phase
- N/A
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
- Status
- RECRUITING
- Phase
- PHASE2
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
- Status
- RECRUITING
- Phase
- PHASE2
Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy
- Status
- COMPLETED
- Phase
- PHASE4
Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
- Status
- COMPLETED
- Phase
- PHASE1
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- Status
- RECRUITING
- Phase
- NA
Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease
- Status
- COMPLETED
- Phase
- N/A
Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- PHASE2
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
- Status
- COMPLETED
- Phase
- N/A
Safety of Nintedanib in Real World in China
- Status
- WITHDRAWN
- Phase
- N/A
Efficacy and Safety of Pirfenidone in CTD-ILD
- Status
- RECRUITING
- Phase
- PHASE4
To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2